Expanding into healthcare markets beyond osteopathic clinics

「In health support, we sell the IFMC.-based healthcare brands Dr.Supporter, My.Supporter and SLEEPINSTANT. Although the number of clinics using IFMC. products increased, revenue fell 33.5% year on year to ¥228,919 thousand because additional orders from those clinics declined.」

「We actively worked to introduce new menus, such as blood-flow improvement programs, using IFMC. products including our healthcare brands Dr.Supporter, My.Supporter and SLEEPINSTANT.」

「In health support, sales of the Group’s IFMC.-based healthcare brands Dr.Supporter and My.Supporter to osteopathic clinics remained solid, with many repeat orders. Sales of IFMC.-treated environmental turf handled by 株式会社イフミックウェルネス as its exclusive distributor also contributed to revenue of ¥563,421 thousand, up 271.5% year on year.」

「In health support, we have provided a broad range of consumer products and services using IFMC. technology.」

「In health support, we have provided a broad range of consumer products and services using IFMC. technology.」

「Although sales of the healthcare brand “Dr.Supporter” remained solid as the Group focused on the brand, revenue declined year on year to ¥365,286 thousand, down 60.6%.」

「Unlike medicines or supplements, IFMC. (Ifmic) does not need to be taken orally. By bringing specially processed fibers close to the body, it is expected to affect nitric oxide (NO) in the blood and promote blood circulation. Believing that exploring IFMC.’s potential could help address health challenges in modern society, where many people experience physical problems, the two companies decided to establish a joint venture and pursue these initiatives together.」

「Selling, general and administrative expenses increased due to sampling to allow many people to experience the effects of the healthcare brand “Dr.Supporter,” which is expected to improve fatigue and relieve muscle fatigue and stiffness by promoting blood circulation, advertising to raise product awareness, and active recruitment of sales personnel.」

「We began selling the healthcare brand “Dr.Supporter” in June 2021. Cost of sales and selling, general and administrative expenses each increased due to sampling, advertising to raise product awareness, active recruitment of sales personnel, and depreciation recorded for additional functions added to the core software “Rese ONE.”」

「The Group began selling the healthcare brand “Dr.Supporter,” treated with IFMC. ingredients and expected to improve fatigue and relieve muscle fatigue and stiffness by promoting blood circulation. Cost of sales and selling, general and administrative expenses each increased due to initiatives to help many people experience Dr.Supporter’s effects and raise product awareness, increased staffing, and depreciation recorded for additional functions added to the core software “Rese ONE.”」

「To extend healthy life expectancy, the Group is considering a broad range of consumer products centered on general medical devices as a new area of focus. We will continue expanding beyond the osteopathic clinic industry into the healthcare industry as a whole because this will enhance the Group’s growth potential.」

「We believe that our consulting and other services can be extended beyond osteopathic clinics to other location-based healthcare businesses, such as acupuncture and moxibustion clinics and private practices. The timing of expansion beyond the osteopathic clinic industry has not been determined, but we will continue to consider entering new markets because doing so would enhance the group’s growth potential.」